The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia. This significant milestone underscores Venus Remedies' commitment to making a substantial ... Dec 29
This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. ... Dec 06
Dr. Alsamarah's selfless bone marrow donation showcases the powerful impact of such generosity. As awareness spreads, we unite in gifting life to those in ... Oct 07
... Jun 14
Children are blessings from god. We all have unconditional love for our children. And what if, one day you come to know that the child ... Sep 17
Imagine losing your loved one due to an avoidable medical error? An error that could with technology be avoided at all costs is causing someone’... Apr 26
Understand the types of blood cancers with Dr Karuna Kumar. Lean the symptoms and treatments available for lymphoma, the cancer of the lymph nodes. ... Oct 19
Imagine losing your loved one due to an avoidable medical error? This harsh reality was faced by Tathagato Rai Dastidar who lost his father and ... Oct 18
On the occasion of World Lymphoma Awareness Day, Dr Soumya Mukherjee sheds light on the symptoms and treatments available for Lymphoma.... Sep 28
... Jul 27
We have seen in the past that many incurable diseases have ultimately become curable and controllable, we can expect the same for haemophilia in the ... Apr 30
India Coronavirus vaccination drive explained... Mar 01
Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia ... Feb 10
The benefits outweighs the risks, says ACS... Feb 06
Annamycin is capable of reaching 6 to 34-fold higher levels of accumulation in the lungs than that of doxorubicin, the primary first-line chemotherapy ... Dec 29
... Dec 08
Risk is greatest in childhood, but does persist into adulthood... Dec 03
Eprenetapopt indicated for the treatment of TP53 Mutant Acute Myeloid Leukemia (AML)... Dec 02
Calquence demonstrated superior progression-free survival and favorable tolerability in both previously untreated and relapsed or refractory patients... Nov 09
CPI-613(devimistat) is indicated for the treatment of soft tissue sarcoma... Oct 31
The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
Novel CAR-T Cell immunotherapy for lymphoma advances to phase II clinical trial ... Oct 06
Moleculin declares new antiviral drug candidates demonstrate in vitro activity against HIV. Also shows activity in Zika and Dengue Fever ... Oct 06
HBI-8000 for Monotherapy Adult T-cell Leukemia-Lymphoma ATL ... Oct 01
The expression "chronic" in incessant myelogenous leukemia demonstrates that this malignant growth will in general advance more gradually than intense types of leukemia. ... Sep 22
-Advertisements-
Monday, April 29, 2024
.jpg)
